ABSTRACT
Background General Practitioners (GPs) play a key role in the treatment of adolescent depression and anxiety, but their capacity to provide effective care may be compromised by long wait times.
Aim To examine the treatments and recommendations of GPs for adolescent patients with depression and/or anxiety in Australia, their referral practices to specialist care and estimated wait times for these, and the perceived impact of long wait times on GPs, their patients and their treatment.
Design, Setting and Methods An online survey of 192 GPs in Australia who treated adolescents (12 to 17 years old) with depression and/or anxiety.
Results GPs frequently referred adolescents with depression and/or anxiety to psychologists. The estimated wait time for psychologists (M: 57 days, SD: 47.9) was four times the proposed acceptable wait time (M: 16.7 days, SD: 27.0). The frequency of medication prescribing almost doubled during the wait time when compared to routine practice (14.6% versus 8.3%, respectively). Almost all GPs (81.8%) increased their level of care due to long wait times but had limited training in youth mental health and knowledge on appropriate strategies to do so effectively.
Conclusion The findings signify the discrepancies between the preferences of GPs for treatment availability in Australia and what they see as the experience for many adolescents with depression and/or anxiety who are referred to specialist care. Greater training, improved communication between referrer and referred services, and digital interventions may help GPs to reduce the negative impacts of long wait times on their adolescent patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by a generous donation from the Buxton Family Foundation, Australian Unity, the Frontiers Technology Clinical Academic Group Industry Connection Seed Funding Scheme, and the UNSW Medicine, Neuroscience, Mental Health and Addiction Theme and SPHERE Clinical Academic Group Collaborative Research Funding. BOD is supported by an NHMRC MRFF Investigator Fellowship (MRF1197249). AEW is supported by an NHMRC Investigator Fellowship (2017521). This work is supported by a NHMRC MRFF Million Minds Grant (MRF2035416).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Human Research Ethics Committee of the University of New South Wales gave ethical approval for this work (HC220107).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the Chief Investigator bridianne.odea{at}flinders.edu.au
